SAN DIEGO----Inovio Biomedical Corporation , a leader in DNA vaccine design, development and delivery, announced today that the company's SynCon™ H1N1 influenza DNA vaccines achieved protective antibody responses against H1N1 swine influenza virus in 100% of pigs immunized with a two-dose vaccine regimen.